A Pilot Study of Soluble Form of LOX-1 as a Novel Biomarker for Neonatal Hypoxic-Ischemic Encephalopathy.
Akamatsu T, Sugiyama T, Aoki Y, Kawabata K, Shimizu M, Okazaki K, Kondo M, Takahashi K, Yokoyama Y, Takahashi N, Goto YI, Oka A, Itoh M.
Akamatsu T, et al. Among authors: shimizu m.
J Pediatr. 2019 Mar;206:49-55.e3. doi: 10.1016/j.jpeds.2018.10.036. Epub 2018 Dec 12.
J Pediatr. 2019.
PMID: 30553539